raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:275555

Preeclampsia

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adult
Status
active

A hypertensive disorder of pregnancy that is characterized by new-onset hypertension with proteinuria presenting after 20 weeks of gestation, and depending on mild or severe forms may initially present with severe headache, visual disturbances, and hyperreflexia.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPreeclampsia
frPré-éclampsieToxémie gravidique
dePräeklampsieSchwangerschaftstoxikose
esPreeclampsia
itPre-eclampsia
nlPre-eclampsieZwangerschapsvergiftiging
ptPré-eclâmpsia
plStan przedrzucawkowy
csPreeklampsie
ukПрееклампсія
zh先兆子痫
trPreeklampsi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM189800Evalidated
OMIM609402BTNTvalidated
OMIM609403BTNTvalidated
OMIM609404BTNTvalidated
OMIM614595BTNTvalidated
ICD-10O14.0BTNTspecificvalidated
ICD-10O14.1BTNTspecificvalidated
ICD-10O14.2BTNTspecificvalidated
ICD-10O14.9BTNTspecificvalidated
ICD-11JA24Especificvalidated
ICD-11JA24.0BTNTspecificvalidated
ICD-11JA24.1BTNTspecificvalidated
MONDO0005081Evalidated
MeSHD011225Evalidated
UMLSC0032914Evalidated
MedDRA10036485Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

3 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CORINMajor susceptibility factor inAssessedHGNC:19012ENSG000001452446052364p12corin, serine peptidase22437503[PMID]
FLT1Major susceptibility factor inAssessedHGNC:3763ENSG0000010275516507013q12.3fms related receptor tyrosine kinase 128628106[PMID]
STOX1Major susceptibility factor inAssessedHGNC:23508ENSG0000016573060939710q22.1storkhead box 121490791[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-5 / 10 00045 / 100 000EuropeValue and classValidatedEuropean Medicines Agency 2011[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

27 annotations · validated 2019-10-22
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0100767Abnormality of the placenta
HP:0005117Elevated diastolic blood pressure
HP:0004421Elevated systolic blood pressure
HP:0000822Hypertension
HP:0000093Proteinuria
Frequent (79-30%)
HP:0410019Epigastric pain
HP:0100598Pulmonary edema
HP:0000083Renal insufficiency
Occasional (29-5%)
HP:0002027Abdominal pain
HP:0006707Abnormality of the hepatic vasculature
HP:0000077Abnormality of the kidney
HP:0000707Abnormality of the nervous system
HP:0000504Abnormality of vision
HP:0002910Elevated circulating hepatic transaminase concentration
HP:0002315Headache
HP:0031418Increased body mass index
HP:0001511Intrauterine growth retardation
HP:0001518Small for gestational age
Very rare (<4-1%)
HP:0001919Acute kidney injury
HP:0002960Autoimmunity
HP:0012622Chronic kidney disease
HP:0003259Elevated circulating creatinine concentration
HP:0005202Helicobacter pylori infection
HP:0000147Polycystic ovaries
HP:0002360Sleep abnormality
HP:0001873Thrombocytopenia
HP:0100651Type I diabetes mellitus

Run the differential on the 5 obligate / very frequent terms

Annotation source: 31590294[PMID]_31487641[PMID]_26693822[PMID]_27094609[PMID]_29037542[PMID]_34033373[PMID]

7

Sources for this card